Acadia Pharmaceuticals Inc.的封面图片
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

制药业

San Diego,California 85,957 位关注者

Acadia is trailblazing breakthroughs in neuroscience to elevate life.

关于我们

Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For over 30 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuro-psychiatric and neuro-rare diseases.

网站
https://Acadia.com
所属行业
制药业
规模
501-1,000 人
总部
San Diego,California
类型
上市公司
创立
1993

地点

  • 主要

    12830 El Camino Real

    Suite 400

    US,California,San Diego,92130-3331

    获取路线
  • 502 Carnegie Center

    Suite 300

    US,New Jersey,Princeton,08540

    获取路线

Acadia Pharmaceuticals Inc.员工

动态

关联主页

相似主页

查看职位

融资